Sovicell GmbH

About:

Sovicell provides absorption, distribution, metabolism, excretion, and toxicology (ADMET) products and services.

Top Investors: MIG Capital, HMW Innovations AG

Description:

Sovicell is dedicated to providing trusted state-of-the-art ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicology) products and services that enable their customers to rapidly obtain accurate and reproducible pharmacokinetic data about their drug candidates or other test substances.

Total Funding Amount:

$1.19M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Deutsch, Sachsen, Germany

Founded Date:

1994-01-01

Contact Email:

contact(AT)sovicell.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2009-05-14

IPO Status:

Private

Industries: